Cargando…
NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells
BACKGROUND: Lipogenesis is required for the optimal growth of many types of cancer cells, it is shown to control the biosynthesis of the lipid bilayer membrane during rapid proliferation and metastasis, provides cancer cells with signaling lipid molecules to support cancer development and make cance...
Autores principales: | Wang, Yinfang, Wan, Xiaohong, Hao, Yilong, Zhao, Yuanyuan, Du, Lanlan, Huang, Yitong, Liu, Zongjun, Wang, Ying, Wang, Nanping, Zhang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637573/ https://www.ncbi.nlm.nih.gov/pubmed/31315616 http://dx.doi.org/10.1186/s12964-019-0389-4 |
Ejemplares similares
-
Effective Inhibition of Xenografts of Hepatocellular Carcinoma (HepG2) by Rapamycin and Bevacizumab in an Intrahepatic Model
por: Ong, Lai-Chun, et al.
Publicado: (2009) -
Diosmetin inhibits cell proliferation and induces apoptosis by regulating autophagy via the mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells
por: Liu, Jie, et al.
Publicado: (2016) -
Lipid synthesis and secretion in HepG2 cells is not affected by ACTH
por: Skoog, Maria, et al.
Publicado: (2010) -
Effects of Amino Acids Supplementation on Lipid and Glucose Metabolism in HepG2 Cells
por: Wang, Shuang, et al.
Publicado: (2022) -
DNMT1/PKR double knockdowned HepG2 (HepG2-DP) cells have high hepatic function and differentiation ability
por: Tanaka-yachi, Rieko, et al.
Publicado: (2022)